Pfizer’s Covid-19 vaccine is set to be one of the most lucrative drugs in the world disgusting!By Annalisa Merelli
Pfizer expects to sell $15 billion worth of Covid-19 vaccines in 2021. That would make it the second-highest revenue-generating drug anytime, anywhere, according to industry reports.
The maker of the first Covid-19 vaccine to be approved for use in advanced markets has released its earning forecasts for 2021 today. Pfizer expects to earn between $59 billion and $61 billion—up from $42 billion it made in 2020. With the exclusion of the vaccine, the company expects its sales to grow 6% in 2021.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.